For instance, RGS1 has been identified as a novel marker and promoter of CD8+ T cell exhaustion, while RGS2 is closely linked to the distribution and function of tumor‐infiltrating immune cells within the CRC tumor microenvironment [36, 37, 38]. The gene discussed is CD8A; the disease is neoplasm.